Abstract
Using data obtained during a retrospective interview study of 30 women who had undergone genetic testing—BRCA1/2 mutation searching—this paper describes how women, previously diagnosed with breast/ovarian cancer, perceive their role in generating genetic information about themselves and their families. It observes that when describing their motivations for undergoing DNA testing and their experiences of disclosing genetic information within the family these women provide care based ethical justifications for their actions. Finally, it argues that generating genetic information and disclosing this information to kin raise different types of ethical issues. The implications of these findings for ethical debates about informed choice in the context of genetic testing are discussed.
Full Text
The Full Text of this article is available as a PDF (105.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bell D., Bennett B. Genetic secrets and the family. Med Law Rev. 2001 Summer;9(2):130–161. doi: 10.1093/medlaw/9.2.130. [DOI] [PubMed] [Google Scholar]
- Burke W., Daly M., Garber J., Botkin J., Kahn M. J., Lynch P., McTiernan A., Offit K., Perlman J., Petersen G. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 26;277(12):997–1003. [PubMed] [Google Scholar]
- Eeles R. A. Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2000 May 25;2(4):283–290. doi: 10.1186/bcr70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ford D., Easton D. F., Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995 Dec;57(6):1457–1462. [PMC free article] [PubMed] [Google Scholar]
- Ford D., Easton D. F., Stratton M., Narod S., Goldgar D., Devilee P., Bishop D. T., Weber B., Lenoir G., Chang-Claude J. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998 Mar;62(3):676–689. doi: 10.1086/301749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goelen G., Rigo A., Bonduelle M., De Grève J. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing. J Clin Oncol. 1999 May;17(5):1595–1600. doi: 10.1200/JCO.1999.17.5.1595. [DOI] [PubMed] [Google Scholar]
- Laurie Graeme T. In defence of ignorance: genetic information and the right not to know. Eur J Health Law. 1999 Jun;6(2):119–132. doi: 10.1163/15718099920522730. [DOI] [PubMed] [Google Scholar]
- Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
- Skene Loane. Patients' rights or family responsibilities? Two approaches to genetic testing. Med Law Rev. 1998 Spring;6(1):1–41. doi: 10.1093/medlaw/6.1.1. [DOI] [PubMed] [Google Scholar]
- Whittemore A. S., Gong G., Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet. 1997 Mar;60(3):496–504. [PMC free article] [PubMed] [Google Scholar]
- Wooster R., Neuhausen S. L., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994 Sep 30;265(5181):2088–2090. doi: 10.1126/science.8091231. [DOI] [PubMed] [Google Scholar]
- d'Agincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics. 2001 Jun;15(3):231–247. doi: 10.1111/1467-8519.00234. [DOI] [PubMed] [Google Scholar]